Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: A preliminary study

Hong Kong Medical Journal

Volumn 11, Issue 5, 2005, Pages 322-330

  Ng, C M ^a   Yuen, H K L ^b   Choi, K L ^a   Chan, M K ^a   Yuen, K T ^a   Ng, Y W ^a   Tiu, S C ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b HONG KONG EYE HOSPITAL   (Hong Kong)

Author keywords

Eye diseases; Graves' disease; Orbit radiation effects; Steroids; Treatment outcome

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EDEMA; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EXTRAOCULAR MUSCLE; EYE INFECTION; EYE IRRITATION; EYE MOVEMENT; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HERPES ZOSTER OTICUS; HOT FLUSH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSOMNIA; IRRADIATION; LEUKOCYTOSIS; MALE; MOON FACE; NOSE INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; ORBITAL IRRADIATION; RANDOMIZED CONTROLLED TRIAL; SAFETY; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; STEROID THERAPY; TREATMENT OUTCOME; VISUAL ACUITY; WEIGHT GAIN;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; GRAVES OPHTHALMOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 27144504735     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993;14:747-93.
2. Wiersinga WM, Smit T, van der Gaag R, Mouritis M, Koornneef L. Clinical presentation of Graves' ophthalmopathy. Ophthalmic Res 1989;21:73-82.
3. Brown J, Coburn JW, Wigod RA, Hiss JM Jr, Dowling JT. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;34:786-95.
4. Cortisone in exophthalmos: report on a therapeutic trial of cortisone and corticotrophin (ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955;268:6-9.
5. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989;321:1349-52.
6. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998;338:73-8.
7. Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol 1978;96:1199-209.
8. Marquez SD, Lum BL, McDougall IR, et al. Long-term results of irradiation for patients with progressive Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 2001;51: 766-74.
9. Wakelkamp IM, Tan H, Saeed P, et al. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study. Ophthalmology 2004;111:1557-62.
10. Prummel MF, Mounts MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy. Lancet 1993;342:949-54.
11. Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB. Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study. Lancet 2000;355:1505-9.
12. Gorman CA, Garrity JA, Fatourechi V, et al. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 2001;108:1523-34.
13. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973;37:276-85.
14. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroid for Graves' ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983;56:1139-44.
15. Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study. J Endocrinol Invest 1991;14: 853-60.
16. Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y. Effect of steroid pulse therapy with and without radiotherapy on Graves' ophthalmopathy. Am J Ophthalmol 2003; 135:285-90.
17. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 1977;44:203-4.
18. Prummel MF, Mourits MP, Berghout A, et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 1989;321:1353-9.
19. Sergott RC, Felberg NT, Savino PJ, Blizzard JJ, Schatz NJ. Graves' ophthalmopathy-immunologic parameters related to corticosteroid therapy. Invest Ophthalmol Vis Sci 1981;20: 173-82.
20. Kahaly G, Beyer J. Immunosuppressant therapy of thyroid eye disease. Klin Wochenschr 1988;66:1049-59.
21. De Rosa G, Menichella G, Della S, et al. Plasma exchange in Graves' ophthalmopathy. Prog Clin Biol Res 1990;337:321-5.
22. Antonelli A, Saracino A, Alberti B, et al. High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy. Acta Endocrinol (Copenh) 1992;126:13-23.
23. Kung AW, Michon J, Tai KS, Chan FL. The effect of somatostatin versus corticosteroid in the treatment of Graves' ophthalmopathy. Thyroid 1996;6:381-4.
24. Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab 2004;89:15-20.
25. Prummel MF, Wiersinga WM. Medical management of Graves' ophthalmopathy. Thyroid 1995;5:231-4.
26. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993;329:1468-75.
27. Gorman CA, Garrity JA, Fatourechi V, et al. The aftermath of orbital radiotherapy for graves' ophthalmopathy. Ophthalmology 2002;109:2100-7.
28. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997;7: 885-9.
29. Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Arch Ophthalmol 1984;102:1473-6.
30. Marcocci C, Bartalena L, Rocchi R, et al. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 2003;88:3561-6.
31. Wiersinga WM, Prummel MF. An evidence-based approach to the treatment of Graves' ophthalmopathy. Endocrinol Metab Clin North Am 2000;29:297-319,vi-vii.